# Fin Risk Analyst

- Symbol: NVDA
- Elapsed: 165.3s

---
All data gathered. I now have everything needed to complete the assessment.

---

# NVIDIA Corporation (NVDA) — Financial Risk Assessment
**FY2026 (ended 2026-01-25) | Price $233.95 | Market Cap ~$5.67T | Sector: Technology / Semiconductors**

---

## 1. Credit Risk Assessment

**Rating: Investment Grade — top-tier (AAA/AA family). Functionally near-zero default risk.**

NVIDIA holds a fortress balance sheet: **$62.6B cash & short-term investments vs. only $11.4B total debt → ~$51.1B net cash**. The company earned an interest coverage ratio of **503x** and pays ~$259M/yr in interest against $102.7B operating cash flow — interest expense is immaterial. Third-party ratings context: NVIDIA has been cited as having reclaimed a **AAA rating** (Moody's Aaa; S&P AA family) — I could not independently confirm exact current ratings/CDS spreads (see Data Gaps), but the ratio evidence fully supports top-tier investment grade regardless.

The only nuance: **Piotroski F-Score of 5/9 ("Moderate")** — the first blemish on an otherwise pristine picture, driven not by deterioration but by *transition scale*: ROA slipped from 65%→58% and gross margin from 75.0%→71.1% because assets (85% YoY growth to $206.8B), inventory ($10.1B→$21.4B) and receivables ($23.1B→$38.5B) ballooned to support the Blackwell ramp. This is a signature of hyper-growth working capital absorption, not credit stress.

---

## 2. Key Financial Risk Metrics Table

| Metric | FY2026 | FY2025 | FY2024 | Assessment |
|---|---|---|---|---|
| Revenue | **$215.9B** | $130.5B | $60.9B | +65% YoY — hypergrowth |
| Gross margin | 71.1% | 75.0% | 72.7% | Strong, slight dilution from ramp |
| Operating margin | 60.4% | 62.4% | 54.1% | Best-in-class |
| Net income | $120.1B | $72.9B | $29.8B | +65% YoY |
| Debt/Equity | **0.07** | 0.13 | 0.26 | Minimal leverage |
| Debt/Assets | 0.06 | 0.09 | 0.17 | Declining |
| Net Debt/EBITDA | **−0.35** (net cash) | −0.02 | 0.11 | Negative = cash-rich |
| Interest Coverage | **503x** | 341x | 133x | Irrelevant constraint |
| Current Ratio | **3.91** | 4.44 | 4.17 | Very strong |
| Quick Ratio | 3.24 | 3.88 | 3.68 | Very strong |
| Cash Ratio | 1.94 | 2.39 | 2.44 | Cash > 2x current liabilities |
| Working Capital | $93.4B | $62.1B | $33.7B | Expanding |
| Altman Z-Score | **6.75** (Safe zone >2.99) | — | — | Far from distress |
| Piotroski F-Score | **5/9** (Moderate) | — | — | Growth-driven drag, not weakness |
| FCF | $96.7B | $60.9B | $27.0B | +59% YoY |
| FCF Margin | 44.8% | 46.6% | 44.3% | Elite cash conversion |
| FCF Yield | **1.69%** | — | — | Rich valuation |

**Liquidity & solvency:** Cash covers total debt 5.5x; equity/assets 76%; assets/liabilities 4.18x. No refinancing cliff — total debt of $11.4B (~$1.0B short-term, ~$7.5B long-term notes) is trivially serviceable out of operating cash flow, and any maturing notes are covered by the cash pile ~5.5x over. Buybacks ($40.1B/yr) and dividends ($1.0B/yr) are fully funded by FCF with huge headroom.

---

## 3. Market Risk Profile (3-year window vs. SPY)

| Metric | Value | Reading |
|---|---|---|
| Annualized Volatility | **44.9%** | ~2x the market — high |
| Beta vs. S&P 500 | **1.92** | Highly cyclical, amplifies drawdowns |
| Max Drawdown (3Y) | **−36.9%** | Nearly 2x typical large-cap drawdown |
| Sharpe Ratio (0% RFR) | **1.07** | Good returns, but high-vol adjusted |

**Market risk is the single largest risk factor in this name.** NVDA behaves like a high-beta 2.0 cyclical despite its financial invulnerability: in a market-triggered selloff, expect roughly twice the index decline. The 37% max drawdown occurred even while fundamentals compounded — a reminder that a $5.67T market cap makes NVDA a top-3 S&P 500 weight, so index concentration and crowding amplify tail moves. Any AI-capex digestion scare, export-control escalation (China), or hyperscaler spend pause could reprise a 30–40% drawdown purely on multiple compression (FCF yield of 1.69% leaves valuation with no cushion).

---

## 4. Downside Scenario Analysis — Revenue −20%

**Assumption set:** Revenue −20% ($215.9B → $172.7B); variable COGS scales with revenue (COGS → ~$50.0B); fixed opex (~$23.1B incl. R&D) held constant; margins on interest/working capital broadly unchanged.

| Line item | Base FY2026 | Stress −20% | Δ |
|---|---|---|---|
| Revenue | $215.9B | $172.7B | −20% |
| Gross profit (GM ~71%) | $153.5B | $122.8B | −20% |
| Operating income | $130.4B | **~$99.7B** | −24% (op-leveraged) |
| Operating margin | 60.4% | ~57.7% | −2.7pp |
| Interest coverage | 503x | **~385x** | Still in triple digits |
| Net debt position | −$51.1B net cash | ~−$51B (WC-insensitive) | Unchanged |
| Altman Z (indicative) | 6.75 | **>5.5** | Remains firmly Safe |

**Verdict: NVIDIA survives a −20% revenue shock with trivial strain.** Even a *−50%* revenue collapse (≈FY2023 revenue levels) would leave the company solidly profitable and net-cash-positive — survivability is not the question at this balance sheet. The scenario that genuinely matters is the *market* consequence: a −20% fundamentals shock combined with 1.9 beta multiple compression could translate to a **40–55% share price drawdown** — a valuation event, not a solvency event. Working-capital risk is the mildest concern: inventory/receivables have ballooned $26B in one year (Blackwell build), and a demand shock would trigger inventory write-downs and WC absorption — but against $62.6B cash this is manageable.

---

## 5. Overall Financial Risk Rating

### **LOW** (financial/solvency risk)
### **HIGH** (market/valuation risk)

The balance-sheet risk is categorically low: net cash, 503x coverage, Z-score 6.75, current ratio 3.9, top-tier credit rating, and $96.7B annual FCF with a 44.8% margin. There is no plausible debt, liquidity, or refinancing failure mode. The material risk is **market risk**: ~45% volatility, 1.92 beta, 37% historical drawdown, and a 1.69% FCF yield that prices in near-perfect execution. This is an equity that cannot hurt you as a *creditor* — only as a *shareholder*.

---

## 6. Key Red Flags

1. **Valuation fragility (primary risk):** FCF yield 1.69% — bond-like quality on a growth-stock multiple; entire downside is multiple compression.
2. **Elevated market sensitivity:** Beta 1.92, annualized vol 44.9%, past drawdown −36.9%; expect ~2x index moves in both directions.
3. **F-Score 5/9 with accruals drag:** NI ($120.1B) exceeds OCF ($102.7B) by ~$17B; working capital absorbed $15.9B. Rapid inventory ($21.4B) and receivables building — risk of write-downs if AI demand inflects.
4. **Gross margin dilution:** 75.0% → 71.1% YoY on Blackwell ramp costs; watch stability as ramp matures.
5. **Customer/concentration & geopolitical risk:** Deep dependence on a handful of hyperscaler/AI capex budgets; China export-control exposure unresolved.
6. **Index concentration feedback:** As a top S&P 500 weight (~$5.7T), forced index flows amplify both rallies and corrections.

**Bottom line:** Do not buy credit protection on NVDA — there is no solvent-entity risk. The risk is intermediate-term multiple risk in a high-beta, high-conviction AI trade. Treat as a balance-sheet-superior, market-risk-heavy position.

---

### Data Gaps
- **Exact current credit rating & CDS spreads:** Could not be independently confirmed via tools (news cited "regains AAA"); rating classification inferred from ratio strength. Flag for verification.
- **Full debt maturity schedule** (individual note maturities/coupons) not retrievable; mitigated by $62.6B cash vs. $11.4B debt — maturities immaterial to risk.
- **Sector peer ratio comparison** not run (AAPL/MSFT/TSM/AVGO available but not pulled) — not material given NVDA's absolute net-cash position.
